Expression vector of human IL6.
Alternative name | SET-0199_12-1 |
---|---|
Clone info. | Expression vector of human IL6. Expression has not yet been confirmed. |
Comment | Derived from Sugano CAS04362. PCR cloning, forward primer: atgaactccttctccacaagc; reverse primer: ctacatttgccgaagagccctc. |
Vector backbone | pCMV_S-FLAG (RDB05956) (Plasmid) |
Size of vector backbone | 5.5 kb |
Selectable markers | Amp^r (E. coli), Neo^r (mammalian cell) |
Gene/insert name | Human IL6 cDNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB06998.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. |
---|---|
Terms and conditions for distribution | The RECIPIENT agrees to describe RIKEN BRC as the source of the MATERIAL and cite Gene 200, 149-156, 1997 in any publication. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 |
---|---|
MTAに書く使用条件 | 発表に際し、理研BRCから入手したことを明記し、指定する文献(Gene, 200, 149-156 (1997))を引用すること。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB06998 | pCMFlag_hsIL6 | DNA solution |
Materials & Methods section:
The pCMFlag_hsIL6 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB06998). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB12822_A4Ggp1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CMV-Forward Sequence file: RDB12822_A4Gga_2.seq |
---|
>06998_12822_A4Gg_CMV-Foward_A08_02.ab1 1 CTTAACAACC TTTCCGCCCC CATTTGACCG CAAATGGGCG GTAGGCGGTG TACGGTGGGA 61 GGTCTTATAT AAGCAGAGCT CTCTGGCTAA CTAGAGAACC CACTGCTTAC TGGCTTATCG 121 AAATTAATAC GACTCACTAT AGGGAGACCC AAGCTGAATT CACCATGGAC TACAAGGACG 181 ATGACGATAA GGCGGCCATG AACTCCTTCT CCACAAGCGC CTTCGGTCCA GTTGCCTTCT 241 CCCTGGGGCT GCTCCTGGTG TTGCCTGCTG CCTTCCCTGC CCCAGTACCC CCAGGAGAAG 301 ATTCCAAAGA TGTAGCCGCC CCACACAGAC AGCCACTCAC CTCTTCAGAA CGAATTGACA 361 AACAAATTCG GTACATCCTC GACGGCATCT CAGCCCTGAG AAAGGAGACA TGTAACAAGA 421 GTAACATGTG TGAAAGCAGC AAAGAGGCAC TGGCAGAAAA CAACCTGAAC CTTCCAAAGA 481 TGGCTGAAAA AGATGGATGC TTCCAATCTG GATTCAATGA GGAGACTTGC CTGGTGAAAA 541 TCATCACTGG TCTTTTGGAG TTTGAGGTAT ACCTAGAGTA CCTCCAGAAC AGATTTGAGA 601 GTAGTGAGGA ACAAGCCAGA GCTGTGCAGA TGAGTACAAA AGTCCTGATC CAGTTCCTGC 661 AGAAAAAGGC AAAGAATCTA GATGCAATAA CCACCCCTGA CCCAACCACA AAATGCCAGC 721 CTGCTGACGA AGCTGCAGGC ACAGAACCAG TGGCTGCAGG ACATGACAAC TCATCTCATT 781 CTGCGCAGCT TTAAAGGAGT TCCTGCAGTC CAGCCTGAGG GCTCTTCGGC AAAATGTAGG 841 GCCCGCTCGA GCATGCATCT AGAGGGCCCT ATTCTATAGT GTCACCCTAA AATGCTAAAG 901 CTCGCTGATC AGCCCTCGAA CTGTGCCTTC TAATTTGCCC AGCCCATCTG TTGTTTGCCC 961 CTCCCCCCGT GCCTTCCTTG ACCCTGGAAG GTGCCAACTC CCCACTTGTC CTTTTCCTAA 1021 TAAAATGAAG GAAAATTGCA TCCGCATTTG TCCTGAGTAG GTGTCCATTT CTATTCTGGG 1081 GGGTTGGGGC TGGGGGGCAA GGACACAAGC CAATGGGGGG AAAGATCTGG GGAAAAAAAC 1141 AAAATAACCA AGGCATTGCT TGGGTAATGC CGGGTGGGCC TTCTAATTGC CCTTCCTGTG 1201 AGAGGCCGTA AAGAACCAGA CTTGGCGACT CTTGCGATAG AAGGTGGTGG TAGC // |
Primer: SV40pro_F_V2 Sequence file: RDB12822_A4Ggb_2.seq |
>06998_12822_A4Gg_SV40pro_F_V2_E01_13.ab1 1 TAGACTTTTG GAGCTAGGCT TTTGCAAAAG CTCCCGGGAG CTTGGATATC CATTTTCGGA 61 TCTGATCAAG AGACAGGATG AGGATCGTTT CGCATGATTG AACAAGATGG ATTGCACGCA 121 GGTTCTCCGG CCGCTTGGGT GGAGAGGCTA TTCGGCTATG ACTGGGCACA ACAGACAATC 181 GGCTGCTCTG ATGCCGCCGT GTTCCGGCTG TCAGCGCAGG GGCGCCCGGT TCTTTTTGTC 241 AAGACCGACC TGTCCGGTGC CCTGAATGAA CTGCAGGACG AGGCAGCGCG GCTATCGTGG 301 CTGGCCACGA CGGGCGTTCC TTGCGCAGCT GTGCTCGACG TTGTCACTGA AGCGGGAAGG 361 GACTGGCTGC TATTGGGCGA AGTGCCGGGG CAGGATCTCC TGTCATCTCA CCTTGCTCCT 421 GCCGAGAAAG TATCCATCAT GGCTGATGCA ATGCGGCGGC TGCATACGCT TGATCCGGCT 481 ACCTGCCCAT TCGACCACCA AGCGAAACAT CGCATCGAGC GAGCACGTAC TCGGATGGAA 541 GCCGGTCTTG TCGATCAGGA TGATCTGGAC GAAGAGCATC AGGGGCTCGC GCCAGCCGAA 601 CTGTTCGCCA GGCTCAAGGC GCGCATGCCC GACGGCGAGG ATCTCGTCGT GACCCATGGC 661 GATGCCTGCT TGCCGAATAT CATGGTGGAA AATGGCCGCT TTTCTGGATT CATCGACTGT 721 GGCCGGCTGG GTGTGGCGGA CCGCTATCAG GACATAGCGT TGGCTACCCG TGATATTGCT 781 GAAGAGCTTG GCGGCGAATG GGCTGACCGC TTCCTCGTGC TTTACGGTAT CGCCGCTCCC 841 GATTCGCAGC GCATCGCCTT CTATCGCCTT CTTGACGAGT TCTTCTGAGC GGGACTCTGG 901 GGGTTCGAAA TGACCGACCA AGCGACGCCC AACCTGCCAT CACGAGATTT CGATTCCACC 961 GCCCGCCCTT CTATGAAAGG TTGGGCTTCG GAATCGTTTT TCCCGGGACG CCCGGCTGGG 1021 ATGATTCCTT CCCAGCGCGG GGGATCTCAT GCTGGGAGTT TCATCACCAC CCCGACCTTG 1081 CTTTATTGCA GGCATAATAA ATG // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
user_report | Yokoyama, C., Interleukin-8 enhances the effect of colchicine on cell death. Biochem. Biophys. Res. Commun. 485 (1): 89-94 (2017). PMID 28189686. [link to RRC of NBRP] |
---|
Featured content